首页 | 本学科首页   官方微博 | 高级检索  
检索        

新生儿监护病房无乳链球菌临床分布及耐药性分析
引用本文:章晟,庄璐,李秋平,韦秀娟,宋婕,张玉佩,封志纯.新生儿监护病房无乳链球菌临床分布及耐药性分析[J].中国感染控制杂志,2017,16(9):804-806.
作者姓名:章晟  庄璐  李秋平  韦秀娟  宋婕  张玉佩  封志纯
作者单位:新生儿监护病房无乳链球菌临床分布及耐药性分析
基金项目:

中国博士后科学基金项目(2013M542472)

摘    要:目的了解医院新生儿监护病房无乳链球菌临床分布及采取耐药性,为抗菌药物的使用及采取干预措施提供参考依据。方法收集2010—2014年某院新生儿监护病房新生儿送检的标本,对新生儿分离的62株无乳链球菌来源科室和药敏试验结果进行分析。结果 62株无乳链球菌的科室分布以足月新生儿监护病房为主,占64.52%;标本来源以血为主,占90.33%,其次为脑脊液(6.45%)、痰和分泌物(均为1.61%)。无乳链球菌对四环素的耐药率最高,为79.03%;对红霉素和克林霉素的耐药率均为74.19%,对左氧氟沙星的耐药率为40.32%,对青霉素、氨苄西林100%敏感。结论无乳链球菌感染在新生儿监护病房中以足月新生儿监护病房为主,对多种抗菌药物有较高的耐药率,青霉素和氨苄西林可作为治疗无乳链球菌感染的优选药物。

关 键 词:新生儿    无乳链球菌    临床分布    耐药性  
收稿时间:2016-11-01
修稿时间:2017/1/12 0:00:00

Clinical distribution and antimicrobial resistance of Streptococcus agalactiae in neonatal intensive care unit
ZHANG Sheng,ZHUANG Lu,LI Qiu ping,WEI Xiu juan,SONG Jie,ZHANG Yu pei,FENG Zhi chun.Clinical distribution and antimicrobial resistance of Streptococcus agalactiae in neonatal intensive care unit[J].Chinese Journal of Infection Control,2017,16(9):804-806.
Authors:ZHANG Sheng  ZHUANG Lu  LI Qiu ping  WEI Xiu juan  SONG Jie  ZHANG Yu pei  FENG Zhi chun
Institution:BaYi Children’s Hospital Affiliated to PLA Army General Hospital, National Engineering Laboratory for Birth Defects Prevention and Control of Key Technology, Beijing Key Laboratory of Pediatric Organ Failure, Beijing 100700, China
Abstract:ObjectiveTo investigate the clinical distribution and antimicrobial resistance of Streptococcus agalactiae(S. agalactiae) in neonatal intensive care unit(NICU), and provide reference for antimicrobial use and intervention measures. MethodsSpecimens from neonates in the NICU of a hospital in 2010-2014 were collected, the department sources and antimicrobial susceptibility testing results of 62 strains of S. agalactiae isolated from children were analyzed. Results62 strains of S. agalactiae were mainly distributed at full term NICU, accounting for 64.52%; the main source of specimens was blood, accounting for 90.33%, followed, by cerebrospinal fluid (6.45%), sputum, and secretion(both were 1.61%). S. agalactiae had the highest resistance rate to tetracycline(79.03%);resistance rates to erythromycin and clindamycin were both 74.19%, resistance rate to levofloxacin was 40.32%, susceptibility rates to penicillin and ampicillin were both 100%. ConclusionS. agalactiae infection mainly occurred in neonates in full term NICU, and has high resistance rate to multiple antimicrobial agents, penicillin and ampicillin can be used as the preferred antimicrobial agents for the treatment of S. agalactiae infection.
Keywords:neonate  Streptococcus agalactiae  clinical distribution  drug resistance  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国感染控制杂志》浏览原始摘要信息
点击此处可从《中国感染控制杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号